| Ytd | -57.92% | |
| 1y | -91.29% |
| Open | 5.41 | Prev Close | 5.52 | Low | 5.15 | High | 5.52 | Mkt Cap | 2.95M |
| Vol | 14.40K | Avg Vol | 1.09M | EPS | 98.07 | P/E | 0.05 | Forward P/E | N/A |
| Beta | 1.04 | Short Ratio | 0.22 | Inst. Own | 1.73% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 04-24 | 50-d Avg | 7.13 | 200-d Avg | 14.47 | 1yr Est | 0.00 |
SPRC News
Toronto, ON – TheNewswire - June 30, 2026 – NeuroThera Labs Inc. (the “ Company ” or “ NeuroThera ”)
According to the share purchase agreement (the "SPA"), pursuant to which, NeuroThera acquire
U.S. stocks rise, Dow Jones gains 200 points. NASDAQ up 0.73%, S&P 500 up 0.56%. Health care sha
Discover why SciSparc Ltd. (NASDAQ: SPRC) stock is surging today after subsidiary NeuroThera Labs re
Amazon Inc (NASDAQ: AMZN) rose in pre-market trading after announcing a strategic collaboration with
SciSparc traded higher after the company announced it had signed a definitive agreement to acquire a
SciSparc ends merger with AutoMax, sets loan repayment terms, and refocuses on CNS drug development
Gainers SciSparc (NASDAQ: SPRC) shares increased by 28.2% to $5.68 during Monday's after-market
Gainers Indaptus Therapeutics (NASDAQ: INDP) stock moved upwards by 108.1% to $6.83 during Friday&#
Gainers bioAffinity Technologies (NASDAQ: BIAF) stock increased by 71.8% to $5.86 during Friday'
Gainers PepGen (NASDAQ: PEPG) stock rose 114.3% to $5.7 during Thursday's regular session. The
U.S. stocks traded lower this morning, with the Nasdaq Composite falling more than 1% on Thursday.
Gainers PepGen (NASDAQ: PEPG) shares rose 141.0% to $6.41 during Thursday's pre-market session.